Cardinal Capital Management Fennec Pharmaceuticals Inc. Transaction History

Cardinal Capital Management

  • $627 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Oct 25, 2018
SELL
$7.84 - $10.83 $204,208 - $282,089
-26,047 Closed
0 $0
Q2 2018

Jul 25, 2018
BUY
$10.05 - $14.33 $140,800 - $200,763
14,010 Added 116.39%
26,047 $272,000
Q4 2017

Feb 01, 2018
BUY
$8.9 - $12.35 $107,129 - $148,656
12,037
12,037 $120,000

Others Institutions Holding FENC

# of Institutions
63
Shares Held
14.8M
Call Options Held
10K
Put Options Held
83.8K
View Full List

About FENNEC PHARMACEUTICALS INC.

FENC Quotes by TradingView
  • Ticker FENC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,067,300
  • Market Cap $169M
  • Description
  • Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...
More about FENC
Track This Portfolio

Track Cardinal Capital Management Portfolio

Follow Cardinal Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cardinal Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Cardinal Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email